Newsletter | November 3, 2025

11.03.25 -- Drug Delivery Product Strategy: Aligning For Execution

FEATURED EDITORIAL

Drug Delivery Product Strategy: Aligning For Execution

In this article, DeGrazio offers recommendations to biopharmaceutical sponsor companies about best practices for aligning strategic product initiatives with functional area execution. 

Nanoparticle Delivery For Gene Therapies

In this episode of Supplier Horizons, host Tom von Gunden talks with Battelle about the promise of polymer nanoparticles as delivery vehicles for treating rare diseases with in vivo gene therapies.

INDUSTRY INSIGHTS

De-Risking Formulations For Delivery With Early Stage Analytics

Review the advancing mass spectrometry, biophysical characterization, automated sample preparation, and high throughput analytics required to deliver medicines in a safe, compliant, and efficient manner.

How Devices, Instructions, And Packaging Work Together To Improve Safety

A medical device's user interface is the entire product system: the device, labeling, packaging, and IFU. These elements are crucial for risk mitigation and must be tested holistically.

Nanoforming Biologics, GLP-1s: From I.V. To Sub Q And Inhaled Delivery

Developing new delivery routes is essential for creating more effective treatments. Nanoforming enables new routes to simplify dosing, enhance patient comfort, and reduce healthcare costs.

Meet Regulatory Requirements With RTU Vials And Cartridges

Sterile manufacturing remains vital, with resilient supply chains preventing shortages. Industry and regulators prioritize integrity as demand surges, making it the fastest-growing pharmaceutical segment.

Orally Disintegrating Tablets For Rapid Onset Migraine Treatment

Examine the case study and learn how formulating an orally disintegrating tablet (ODT) created a convenient dosage form with a shorter Tmax for the treatment of acute migraine.

3D Screen Printing: Tableting Solutions For Patient-Centric Therapies

Explore 3D screen printing’s potential to revolutionize pharmaceutical manufacturing with scalable, customizable, multi-drug tablets and precise, patient-centric drug release profiles.

SOLUTIONS

Container Closure Integrity For Early Development Small Quantities

Autoinjector For Deep Intramuscular Delivery